BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 28974895)

  • 41. Prognostic nutritional index predicts survival and correlates with systemic inflammatory response in advanced pancreatic cancer.
    Geng Y; Qi Q; Sun M; Chen H; Wang P; Chen Z
    Eur J Surg Oncol; 2015 Nov; 41(11):1508-14. PubMed ID: 26343824
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Complex relationship of body mass index with mortality in patients with critical limb ischemia undergoing endovascular treatment.
    Murata N; Soga Y; Iida O; Yamauchi Y; Hirano K; Kawasaki D; Fujihara M; Tomoi Y
    Eur J Vasc Endovasc Surg; 2015 Mar; 49(3):297-305. PubMed ID: 25524520
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes.
    Frere C; Bournet B; Gourgou S; Fraisse J; Canivet C; Connors JM; Buscail L; Farge D;
    Gastroenterology; 2020 Apr; 158(5):1346-1358.e4. PubMed ID: 31843588
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mortalin expression in pancreatic cancer and its clinical and prognostic significance.
    Cui X; Li Z; Piao J; Li J; Li L; Lin Z; Jin A
    Hum Pathol; 2017 Jun; 64():171-178. PubMed ID: 28412209
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sineoculis homeobox homolog 1 protein overexpression as an independent biomarker for pancreatic ductal adenocarcinoma.
    Jin A; Xu Y; Liu S; Jin T; Li Z; Jin H; Lin L; Lin Z
    Exp Mol Pathol; 2014 Feb; 96(1):54-60. PubMed ID: 24263054
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Body mass index as a prognostic factor in epithelial ovarian cancer and correlation with clinico-pathological factors.
    Skírnisdóttir I; Sorbe B
    Acta Obstet Gynecol Scand; 2010; 89(1):101-7. PubMed ID: 19878086
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: A retrospective cohort study.
    Ninomiya G; Fujii T; Yamada S; Yabusaki N; Suzuki K; Iwata N; Kanda M; Hayashi M; Tanaka C; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
    Int J Surg; 2017 Mar; 39():45-51. PubMed ID: 28110029
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of Locoregional Control With High Body Mass Index in Women Undergoing Breast Conservation Therapy for Early-Stage Breast Cancer.
    Bergom C; Kelly T; Bedi M; Saeed H; Prior P; Rein LE; Szabo A; Wilson JF; Currey AD; White J
    Int J Radiat Oncol Biol Phys; 2016 Sep; 96(1):65-71. PubMed ID: 27511848
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ezrin protein overexpression predicts the poor prognosis of pancreatic ductal adenocarcinomas.
    Piao J; Liu S; Xu Y; Wang C; Lin Z; Qin Y; Liu S
    Exp Mol Pathol; 2015 Feb; 98(1):1-6. PubMed ID: 25445504
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Body mass index and mortality in patients with type 2 diabetes mellitus: A prospective cohort study of 11,449 participants.
    Liu H; Wu S; Li Y; Sun L; Huang Z; Lin L; Liu Y; Ji C; Zhao H; Li C; Song L; Cong H
    J Diabetes Complications; 2017 Feb; 31(2):328-333. PubMed ID: 27887863
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Postdiagnosis body mass index and risk of mortality in colorectal cancer survivors: a prospective study and meta-analysis.
    Schlesinger S; Siegert S; Koch M; Walter J; Heits N; Hinz S; Jacobs G; Hampe J; Schafmayer C; Nöthlings U
    Cancer Causes Control; 2014 Oct; 25(10):1407-18. PubMed ID: 25037235
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression of microRNA-218 in human pancreatic ductal adenocarcinoma and its correlation with tumor progression and patient survival.
    Zhu Z; Xu Y; Du J; Tan J; Jiao H
    J Surg Oncol; 2014 Feb; 109(2):89-94. PubMed ID: 24166773
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pancreatic ductal adenocarcinoma: is there a survival difference for R1 resections versus locally advanced unresectable tumors? What is a "true" R0 resection?
    Konstantinidis IT; Warshaw AL; Allen JN; Blaszkowsky LS; Castillo CF; Deshpande V; Hong TS; Kwak EL; Lauwers GY; Ryan DP; Wargo JA; Lillemoe KD; Ferrone CR
    Ann Surg; 2013 Apr; 257(4):731-6. PubMed ID: 22968073
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Association between body mass index and risk of lung cancer in non-smoking males: a prospective cohort study].
    Xie SH; Wang G; Guo LW; Chen SH; Su K; Li F; Chang S; Feng XS; Lyu ZY; Chen YH; Ren JS; Yin J; Cui H; Wu SL; Dai M; Li N; He J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Sep; 37(9):1213-1219. PubMed ID: 27655565
    [No Abstract]   [Full Text] [Related]  

  • 55. Statin and Metformin Use Prolongs Survival in Patients With Resectable Pancreatic Cancer.
    Kozak MM; Anderson EM; von Eyben R; Pai JS; Poultsides GA; Visser BC; Norton JA; Koong AC; Chang DT
    Pancreas; 2016 Jan; 45(1):64-70. PubMed ID: 26474429
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Body Mass Index Trajectories Across the Adult Life Course and Pancreatic Cancer Risk.
    Arjani S; Saint-Maurice PF; Julián-Serrano S; Eibl G; Stolzenberg-Solomon R
    JNCI Cancer Spectr; 2022 Nov; 6(6):. PubMed ID: 36255251
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios.
    Asari S; Matsumoto I; Toyama H; Shinzeki M; Goto T; Ishida J; Ajiki T; Fukumoto T; Ku Y
    Surg Today; 2016 May; 46(5):583-92. PubMed ID: 26108488
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Is there any survival advantage of obesity in Southern European haemodialysis patients?
    Chazot C; Gassia JP; Di Benedetto A; Cesare S; Ponce P; Marcelli D
    Nephrol Dial Transplant; 2009 Sep; 24(9):2871-6. PubMed ID: 19369686
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Doublecortin and CaM kinase-like-1 as an independent prognostic factor in patients with resected pancreatic carcinoma.
    Nishio K; Kimura K; Amano R; Nakata B; Yamazoe S; Ohira G; Miura K; Kametani N; Tanaka H; Muguruma K; Hirakawa K; Ohira M
    World J Gastroenterol; 2017 Aug; 23(31):5764-5772. PubMed ID: 28883702
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early onset pancreatic malignancies: Clinical characteristics and survival associations.
    Beeghly-Fadiel A; Luu HN; Du L; Shi C; McGavic DP; Parikh AA; Raskin L
    Int J Cancer; 2016 Nov; 139(10):2169-77. PubMed ID: 27416564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.